Wide variation seen in gluten-free food prescribing

Wide variation seen in gluten-free food prescribing

April 20 2018 Wide variation in gluten-free food (GFF) prescribing does not appear to be driven...

‘Caution in use’ alert issued for Inhixa solution for injection

‘Caution in use’ alert issued for Inhixa solution for injection

April 20 2018 A Class 4 medicines defect alert has been issued relating to Inhixa (enoxaparin...

Views sought on improving health services for people with sensory loss

Views sought on improving health services for people with sensory loss

April 20 2018 Primary care professionals are being asked for views on how to help improve...

Minister: GPs are not precluded from prescribing OTC medicines, but should follow guidance

Minister: GPs are not precluded from prescribing OTC medicines, but should follow guidance

April 20 2018 Doctors have not been prevented from prescribing over-the counter medicines, but...

Epipen manufacturing delays causing stock shortage

Epipen manufacturing delays causing stock shortage

April 17 2018 A manufacturing delay is causing problems around availability of Epipen (Senior)...

  • Wide variation seen in gluten-free food prescribing

    Wide variation seen in gluten-free food prescribing

    Friday, 20 April 2018 16:48
  • ‘Caution in use’ alert issued for Inhixa solution for injection

    ‘Caution in use’ alert issued for Inhixa solution for injection

    Friday, 20 April 2018 16:43
  • Views sought on improving health services for people with sensory loss

    Views sought on improving health services for people with sensory loss

    Friday, 20 April 2018 16:39
  • Minister: GPs are not precluded from prescribing OTC medicines, but should follow guidance

    Minister: GPs are not precluded from prescribing OTC medicines, but should follow guidance

    Friday, 20 April 2018 16:31
  • Epipen manufacturing delays causing stock shortage

    Epipen manufacturing delays causing stock shortage

    Tuesday, 17 April 2018 08:53

a scottish flag image cbOctober 27 2017

Scottish ministers have agreed to allow women to use misoprostol at home to terminate an early pregnancy, having taken mifepristone at a clinic.

An amendment to the regulations approves the home of a pregnant woman who is undergoing treatment to terminate a pregnancy as a suitable place where that treatment can occur, providing that the pregnant woman has:

  • attended a clinic where she has been prescribed the combination of mifepristone and misoprostol to terminate the pregnancy; and
  • taken mifepristone at that clinic and wants to carry out the treatment at home.

The procedure is approved for women are up to 9 weeks and 6 days into gestation.

The document introducing the regulatory change, which came into effect on October 27 2017, says that “evidence has clearly demonstrated that early medical discharge with at home self-administration of misoprostol is a safe method of abortion, with no higher risk of complications than medical abortions as a day case.

“This offers additional choice to women requesting an abortion and, in addition to practical and logistical benefits, enables women to complete treatment in an environment where they feel most comfortable.”

It sets out inclusion criteria, contra-indications, cautions in use, and the procedure for using the drugs.

While the mifepristone has to be given at the clinic, the woman will be given a ‘take home’ pack of misoprostol tablets. “Traditional administration has been by the vaginal route, but sublingual route and buccal routes are as effective and the patient should be advised on how to self-administer by the preferred route,” says the guidance. Ordinarily, the misoprostol should be taken 24-48 hours after the mifepristone.

Link:
Scottish Government announcement ‘Abortion: improvement to existing services: approval for Misoprostol to be taken at home’                  

Professional News

April 20 2018 Wide variation in gluten-free food (GFF) prescribing does not appear to be driven by obvious medical factors, a study has suggested. 
April 20 2018 Wide variation in gluten-free food (GFF) prescribing does not appear to be driven by obvious medical factors, a study has suggested.  GFF prescribing is less likely to occur in areas...